AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
64 hedge funds and large institutions have $45.7M invested in Agile Therapeutics in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 15 increasing their positions, 19 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 27
42% less capital invested
Capital invested by funds: $79.5M → $45.7M (-$33.8M)
Holders
64
Holding in Top 10
1
Calls
$584K
Puts
$151K
Top Buyers
| 1 | +$2M | |
| 2 | +$994K | |
| 3 | +$601K | |
| 4 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
+$321K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$309K |
Top Sellers
| 1 | -$5.04M | |
| 2 | -$1.05M | |
| 3 | -$758K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$683K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$493K |